Phosphate binder use and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS): Evaluation of possible confounding by nutritional status

American Journal of Kidney Diseases

Volumn 60, Issue 1, 2012, Pages 90-101

  Lopes, Antonio Alberto ^a   Tong, Lin ^b   Thumma, Jyothi ^b   Li, Yun ^c   Fuller, Douglas S ^b   Morgenstern, Hal ^c   Bommer, Jürgen ^d   Kerr, Peter G ^e   Tentori, Francesca ^b   Akiba, Takashi ^f   Gillespie, Brenda W ^c   Robinson, Bruce M ^b   Port, Friedrich K ^b   Pisoni, Ronald L ^b  

^a FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^b ARBOR RESEARCH COLLABORATIVE FOR HEALTH   (United States)

^c UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e MONASH UNIVERSITY   (Australia)

^f TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

DOPPS; hemodialysis; instrumental variable; mortality; nutrition; phosphate binder; serum phosphorus; survival

Indexed keywords

ALBUMIN; CREATININE; PHOSPHATE BINDING AGENT; PHOSPHORUS;

ADULT; AGE DISTRIBUTION; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BODY MASS; CACHEXIA; COHORT ANALYSIS; COMORBIDITY; CREATININE BLOOD LEVEL; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERPHOSPHATEMIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUTRITIONAL STATUS; PHOSPHATE BLOOD LEVEL; PRESCRIPTION; PROSPECTIVE STUDY; PROTEIN DEGRADATION; SURVIVAL;

COHORT STUDIES; COMORBIDITY; DIALYSIS SOLUTIONS; FEMALE; HUMANS; HYPERPHOSPHATEMIA; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; NUTRITIONAL STATUS; PHOSPHATES; PHYSICIAN'S PRACTICE PATTERNS; RENAL DIALYSIS;

EID: 84862804470     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2011.12.025     Document Type: Article

References (30)

1. Lopes AA, Elder SJ, Ginsberg N, et al. Lack of appetite in haemodialysis patients - associations with patient characteristics, indicators of nutritional status and outcomes in the international DOPPS. Nephrol Dial Transplant. 2007;22:3538-3546.
2. Leavey SF, Strawderman RL, Jones CA, Port FK, Held PJ. Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis. 1998;31:997-1006.
3. Tentori F, Blayney MJ, Albert JM, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2008;52:519-530.
4. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998;31:607-617.
5. Lopes AA, Bragg-Gresham JL, Elder SJ, et al. Independent and joint associations of nutritional status indicators with mortality risk among chronic hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). J Ren Nutr. 2010;20:224-234.
6. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. Am J Kidney Dis. 2003;42(4)(suppl 3):S1-S201.
7. Shinaberger CS, Greenland S, Kopple JD, et al. Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr. 2008;88:1511-1518.
8. Lynch KE, Lynch R, Curhan GC, Brunelli SM. Prescribed dietary phosphate restriction and survival among hemodialysis patients. Clin J Am Soc Nephrol. 2011;6:620-629.
9. Isakova T, Gutierrez OM, Chang Y, et al. Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol. 2009;20:388-396.
10. Vanbelleghem H, Vanholder R, Levin NW, et al. The Kidney Disease: Improving Global Outcomes website: comparison of guidelines as a tool for harmonization. Kidney Int. 2007;71:1054-1061.
11. Winkelmayer WC, Liu J, Kestenbaum B. Comparative effectiveness of calcium-containing phosphate binders in incident U.S. dialysis patients. Clin J Am Soc Nephrol. 2011;6:175-183.
12. Young EW, Goodkin DA, Mapes DL, et al. The Dialysis Outcomes and Practice Patterns Study (DOPPS): an international hemodialysis study. Kidney Int Suppl. 2000;74:S74-S81.
13. Pisoni RL, Gillespie BW, Dickinson DM, Chen K, Kutner MH, Wolfe RA. The Dialysis Outcomes and Practice Patterns Study (DOPPS): design, data elements, and methodology. Am J Kidney Dis. 2004;44:7-15.
14. SAS Institute Inc. SAS/STAT User's Guide. Vol 2. Version 8. Cary, NC: SAS Institute; 2002.
15. Angrist JD, Pischke J. Mostly Harmless Econometrics: An Empiricist's Companion. Princeton, NJ: Princeton University Press; 2009.
16. Klein JP, Moeschberger ML. Survival Analysis Techniques for Censored and Truncated Data. New York, NY: Springer; 1997:417.
17. Stock JH, Wright JH, Yogo M. A survey of weak instruments and weak identification in generalized method of moments. J Bus Econ Stat. 2002;20:518-529.
18. Steiger D, Stock JH. Instrumental variables regression with weak instruments. Econometrica. 1997;65:557-586.
19. Little RJA, Rubin DB. Statistical Analysis With Missing Data. Hoboken, NJ: JohnWiley & Sons; 2002.
20. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147:573-577.
21. Kovesdy CP, Kuchmak O, Lu JL, Kalantar-Zadeh K. Outcomes associated with phosphorus binders in men with non-dialysis-dependent CKD. Am J Kidney Dis. 2010;56:842-851.
22. Mehrotra R, Duong U, Jiwakanon S, et al. Serum albumin as a predictor of mortality in peritoneal dialysis: comparisons with hemodialysis. Am J Kidney Dis. 2011;58:418-428.
23. Moreau-Gaudry X, Guebre-Egziabher F, Jean G, et al. Serum creatinine improves body mass index survival prediction in hemodialysis patients: a 1-year prospective cohort analysis from the ARNOS Study. J Ren Nutr. 2011;21:369-375.
24. Walther CP, Carter CW, Low CL, et al. Interdialytic creatinine change versus predialysis creatinine as indicators of nutritional status in maintenance hemodialysis [published online ahead of print July 20, 2011]. Nephrol Dial Transplant.
25. Brookhart MA, Wang PS, Solomon DH, Schneeweiss S. Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable. Epidemiology. 2006;17:268-275.
26. Brookhart MA, Rassen JA, Wang PS, Dormuth C, Mogun H, Schneeweiss S. Evaluating the validity of an instrumental variable study of neuroleptics: can between-physician differences in prescribing patterns be used to estimate treatment effects? Med Care. 2007;45(10)(suppl 2):S116-S122.
27. Cleary DJ, Matzke GR, Alexander AC, Joy MS. Medication knowledge and compliance among patients receiving long-term dialysis. Am J Health Syst Pharm. 1995;52:1895-1900.
28. Arenas MD, Malek T, Gil MT, Moledous A, Alvarez-Ude F, Reig-Ferrer A. Challenge of phosphorus control in hemodialysis patients: a problem of adherence? J Nephrol. 2010;23:525-534.
29. Ketteler M, Bongartz P, Westenfeld R, et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet. 2003;361:827-833.
30. Gutierrez OM, Mannstadt M, Isakova T, et al. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med. 2008;359:584-592.